Cuoretech

Cuoretech Pty Ltd develops software for the analysis of electrical signals measured from the heart. This involves applying signal processing technology to unravel complex electrical behaviour.

Our customers are the leading cardiologists and researchers investigating cures for abnormal heart rhythms.
Our flagship product is CEPAS (Cardiac ElectroPhysiology Analysis System) that has been the result of development over several years. It can be used for both real time and offline analysis. We typically customise it to suit specific user needs and to interface to specific hospital laboratory hardware. Atrial Fibrillation is a commonly occurring arrhythmia that is currently the focus of much research. CEPAS has implemented many tools used to analyse fibrillatory signals. Recently Phase Mapping, a technique that has been used to detect rotors causing Atrial Fibrillation, has been implemented.

Company’s Keywords:

cardiac signal processing, medical devices